Isoniazid Preventive Therapy in Contacts of Multidrug-Resistant Tuberculosis

Rationale: The World Health Organization recommends the use of isoniazid (INH) alone or in combination with rifapentine to treat latent tuberculosis infections. The recent rise of drug-resistant tuberculosis has complicated the choice of treatment regimen for latent tuberculosis infection. Objective...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Respir Crit Care Med
Auteurs principaux: Huang, Chuan-Chin, Becerra, Mercedes C., Calderon, Roger, Contreras, Carmen, Galea, Jerome, Grandjean, Louis, Lecca, Leonid, Yataco, Rosa, Zhang, Zibiao, Murray, Megan
Format: Artigo
Langue:Inglês
Publié: American Thoracic Society 2020
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7560814/
https://ncbi.nlm.nih.gov/pubmed/32551948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201908-1576OC
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires